What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
The scientist’s investigation covers issues in Internal medicine, Hepatocellular carcinoma, Cancer research, Pathology and Immunohistochemistry.
His studies deal with areas such as Gastroenterology, Endocrinology and Oncology as well as Internal medicine.
His work carried out in the field of Hepatocellular carcinoma brings together such families of science as Grading, Hepatectomy, Radiology and Mr imaging.
His Cancer research research incorporates elements of Carcinogenesis, Apoptosis, Cell cycle, Combination therapy and Cytotoxic T cell.
The concepts of his Pathology study are interwoven with issues in Magnetic resonance imaging, Cancer and Angiogenesis, Neovascularization.
His Immunohistochemistry research is multidisciplinary, relying on both Survival rate, Regulation of gene expression, Western blot and Pancreas.
His most cited work include:
- International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study (665 citations)
- Reprogramming of mouse and human cells to pluripotency using mature microRNAs. (617 citations)
- CD13 is a therapeutic target in human liver cancer stem cells (418 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Internal medicine, Hepatocellular carcinoma, Surgery, Oncology and Gastroenterology.
His research related to Cancer, Chemotherapy, Gemcitabine, Combination therapy and Pancreatic cancer might be considered part of Internal medicine.
His Cancer study frequently draws connections to other fields, such as Cancer research.
His Hepatocellular carcinoma research incorporates themes from Cirrhosis, Carcinoma, Pathology, Radiology and Hepatectomy.
His biological study spans a wide range of topics, including Colorectal cancer and Cisplatin.
His research on Gastroenterology often connects related areas such as Survival rate.
He most often published in these fields:
- Internal medicine (39.87%)
- Hepatocellular carcinoma (26.84%)
- Surgery (23.68%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (39.87%)
- Surgery (23.68%)
- Cancer (14.61%)
In recent papers he was focusing on the following fields of study:
Hiroaki Nagano focuses on Internal medicine, Surgery, Cancer, Chemotherapy and Cancer research.
His research in Internal medicine intersects with topics in Gastroenterology and Oncology.
His Surgery research is multidisciplinary, incorporating perspectives in Neoadjuvant therapy and Incidence.
His Cancer study combines topics in areas such as Biomarker and Surgical oncology.
Hiroaki Nagano interconnects Cancer stem cell, T cell, Immune system, Antigen and Metastasis in the investigation of issues within Cancer research.
The various areas that Hiroaki Nagano examines in his Hepatocellular carcinoma study include Hepatectomy, Liver function, Cirrhosis and Proportional hazards model.
Between 2018 and 2021, his most popular works were:
- Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH-HCC guidelines) 2019 update. (91 citations)
- Correction: Intratumoural-infiltrating CD4 + and FOXP3 + T cells as strong positive predictive markers for the prognosis of resectable colorectal cancer (20 citations)
- Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer. (19 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Surgery
His scientific interests lie mostly in Internal medicine, Cancer research, Cancer, Hepatocellular carcinoma and Chemotherapy.
His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology and Oncology.
His Cancer research study incorporates themes from T cell, Chimeric antigen receptor, Antigen, Metastasis and Programmed cell death.
His studies in Cancer integrate themes in fields like Surgical oncology and Biopsy, Pathology.
He has researched Hepatocellular carcinoma in several fields, including Cirrhosis, Medical physics, Proportional hazards model and Hepatology.
He combines subjects such as Patient demographics, Randomized controlled trial and Microsatellite instability with his study of Chemotherapy.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
